Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ernest Hamel

Showing results (31-40 of 272) with videos related to

Pageof 28
Sort By:
Pharmaceutical Research|July 21, 2012
Novel water-soluble substituted pyrrolo[3,2-d]pyrimidines: design, synthesis, and biological evaluation as antitubulin antitumor agentsAleem Gangjee, Roheeth K Pavana, Wei Li, et al.
Bioorganic & Medicinal Chemistry|March 8, 2023
Simple monocyclic pyrimidine analogs as microtubule targeting agents binding to the colchicine siteShruti Choudhary, Krishna Kaku, Andrew J Robles, et al.
Journal of Medicinal Chemistry|July 31, 2013
Structure-activity relationship and in vitro and in vivo evaluation of the potent cytotoxic anti-microtubule agent N-(4-methoxyphenyl)-N,2,6-trimethyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-aminium chloride and its analogues as antitumor agentsAleem Gangjee, Ying Zhao, Sudhir Raghavan, et al.
European Journal of Biochemistry|September 3, 2003
Dolastatin 15 binds in the vinca domain of tubulin as demonstrated by Hummel-Dreyer chromatographyZobeida Cruz-Monserrate, Jeffrey T Mullaney, Patrick G Harran, et al.
Journal of the American Chemical Society|January 31, 2008
Evolution of the total syntheses of ustiloxin natural products and their analoguesPixu Li, Cory D Evans, Yongzhong Wu, et al.
Journal of Medicinal Chemistry|February 20, 2015
Development of a novel class of tubulin inhibitor from desmosdumotin B with a hydroxylated bicyclic B-ringKyoko Nakagawa-Goto, Akifumi Oda, Ernest Hamel, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2002
Antitumor agents. Part 215: antitubulin effects of cytotoxic B-ring modified allocolchicinoidsShiqing Han, Ernest Hamel, Kenneth F Bastow, et al.
Journal of Medicinal Chemistry|September 30, 2015
Novel 3-Substituted 7-Phenylpyrrolo[3,2-f]quinolin-9(6H)-ones as Single Entities with Multitarget Antiproliferative ActivityDavide Carta, Roberta Bortolozzi, Ernest Hamel, et al.
Angewandte Chemie (International Ed. in English)|January 14, 2009
Enantioselective synthesis of (+)-chamaecypanone C: a novel microtubule inhibitorSuwei Dong, Ernest Hamel, Ruoli Bai, et al.
International Journal of Cancer|September 10, 2005
CB694, a novel antimitotic with antitumor activitiesKimberly N Weiderhold, Deborah A Randall-Hlubek, Lisa A Polin, et al.
Pageof 28

Showing results (31-40 of 272) with videos related to

Sort By:
Pageof 28
Pharmaceutical Research|July 21, 2012
Novel water-soluble substituted pyrrolo[3,2-d]pyrimidines: design, synthesis, and biological evaluation as antitubulin antitumor agentsAleem Gangjee, Roheeth K Pavana, Wei Li, et al.
Bioorganic & Medicinal Chemistry|March 8, 2023
Simple monocyclic pyrimidine analogs as microtubule targeting agents binding to the colchicine siteShruti Choudhary, Krishna Kaku, Andrew J Robles, et al.
Journal of Medicinal Chemistry|July 31, 2013
Structure-activity relationship and in vitro and in vivo evaluation of the potent cytotoxic anti-microtubule agent N-(4-methoxyphenyl)-N,2,6-trimethyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-aminium chloride and its analogues as antitumor agentsAleem Gangjee, Ying Zhao, Sudhir Raghavan, et al.
European Journal of Biochemistry|September 3, 2003
Dolastatin 15 binds in the vinca domain of tubulin as demonstrated by Hummel-Dreyer chromatographyZobeida Cruz-Monserrate, Jeffrey T Mullaney, Patrick G Harran, et al.
Journal of the American Chemical Society|January 31, 2008
Evolution of the total syntheses of ustiloxin natural products and their analoguesPixu Li, Cory D Evans, Yongzhong Wu, et al.
Journal of Medicinal Chemistry|February 20, 2015
Development of a novel class of tubulin inhibitor from desmosdumotin B with a hydroxylated bicyclic B-ringKyoko Nakagawa-Goto, Akifumi Oda, Ernest Hamel, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2002
Antitumor agents. Part 215: antitubulin effects of cytotoxic B-ring modified allocolchicinoidsShiqing Han, Ernest Hamel, Kenneth F Bastow, et al.
Journal of Medicinal Chemistry|September 30, 2015
Novel 3-Substituted 7-Phenylpyrrolo[3,2-f]quinolin-9(6H)-ones as Single Entities with Multitarget Antiproliferative ActivityDavide Carta, Roberta Bortolozzi, Ernest Hamel, et al.
Angewandte Chemie (International Ed. in English)|January 14, 2009
Enantioselective synthesis of (+)-chamaecypanone C: a novel microtubule inhibitorSuwei Dong, Ernest Hamel, Ruoli Bai, et al.
International Journal of Cancer|September 10, 2005
CB694, a novel antimitotic with antitumor activitiesKimberly N Weiderhold, Deborah A Randall-Hlubek, Lisa A Polin, et al.
Pageof 28